Search Results - "Tjong, M"

Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung – The Knockout Punch by Tjong, M.C., Louie, A.V., Singh, A.K., Videtic, G., Stephans, K., Plumridge, N., Harden, S., Slotman, B.J., Alongi, F., Guckenberger, M., Siva, S.

“…This overview summarises the current evidence on efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers…”
Get full text

Radiation-induced Lumbosacral Plexopathy after Spine Stereotactic Body Radiotherapy – Should the Lumbosacral Plexi be Contoured? by Tjong, M.C., Moraes, F.Y., Yamada, Y., Brar, S., Cederquist, G.Y., Yorke, E., Schmitt, A.M., Shultz, D.B.

Get full text

Inherent Margin due to Tumor Shrinkage Can Decrease Target Delineation Margin Protocols in IMRT Treatment for Head and Neck Carcinomas by Cifuentes Gaitan, J, Chin, L, Tjong, M, Poon, I

Get full text

Stereotactic Ablative Radiation Therapy for Pulmonary Oligometastases and Oligoprogression by Helou, J, Thibault, I, Yeung, L, Poon, I, Tjong, M, Chiang, A.S, Jain, S, Soliman, H, Cheung, P

Get full text

External validation of Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radiotherapy by Tjong, M.C., Zhang, S.C., Gasho, J.O., Silos, K.D., Gay, C., McKenzie, E.M., Steers, J., Bitterman, D.S., Nikolova, A.P., Nohria, A., Hoffmann, U., Brantley, K.D., Mak, R.H., Atkins, K.M.

“…•Coronary heart disease, Hypertension, and Logarithmic LADV15 (CHyLL model), but not mean heart dose performed well in predicting MACE among this external…”
Get full text

PO-1213: Pelvic radiotherapy in node positive bladder cancer – outcomes in a selected cohort by Tjong, M., Lunsky, I., Ajib, K., Sridhar, S.S., Fleshner, N., Zlotta, A., Berlin, A., Kulkarni, G.S., Chung, P.

Get full text

PD-0565 Outcomes of the use of partial boost in radical radiotherapy in muscle invasive bladder cancer by Navarro, I., Arulanantham, S., Liu, Z., Tjong, M., Kong, V., Malkov, V., Tadic, T., Fleshner, N., Kulkarni, G., Zlotta, A., Catton, C., Berlin, A., Sridhar, S., Jiang, D.(., Chung, P., Raman, S.

Get full text

Cardiac Radiation Dose and Patient Risk Factors for Predicting Major Adverse Cardiac Events in Lung Cancer Patients by Tjong, M.C., Bitterman, D.S., Brantley, K.D., Nohria, A., Hoffman, U., Atkins, K.M., Mak, R.H.

“…Thoracic radiotherapy (TRT) is a mainstay treatment for locally advanced non-small cell lung cancer (LA-NSCLC). Mean heart dose (MHD) and left anterior…”
Get full text

Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic Tumors by Tan, H., Nusrat, H., Li, G., Poon, I., Tsao, M., Ung, Y.C., Chen, H., Tjong, M.C., Cheung, P., Louie, A.V.

“…The utilization of stereotactic body radiotherapy (SBRT) in the management of ultra-central thoracic tumors is increasing. We sought to evaluate toxicity and…”
Get full text

A Systematic Approach for Integrating Machine Learning Models into the Clinic by Savjani, Ricky

Get full text

Analysis of Patient Reported Outcomes for Stage IV Non-Small Cell Lung Cancer Patients in Ontario by Tjong, M.C., Doherty, M., Tan, H., Chan, W.C., Zhao, H., Hallet, J., Darling, G., Kidane, B., Wright, F., Mahar, A., Davis, L.E., Delibasic, V., Parmar, A., Mittmann, N., Coburn, N.G., Louie, A.V.

“…Stage IV non-small cell lung cancer (NSCLC) is associated with substantial disease and treatment-related morbidity. In Ontario, Canada, patient reported…”
Get full text

External validation of C ardiac disease, H ypertension, and L ogarithmic L eft anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radiotherapy by Tjong, M C, Zhang, S C, Gasho, J O, Silos, K D, Gay, C, McKenzie, E M, Steers, J, Bitterman, D S, Nikolova, A P, Nohria, A, Hoffmann, U, Brantley, K D, Mak, R H, Atkins, K M

“…Major adverse cardiac events(MACE) are prevalent in patients with locally advanced-non-small cell lung cancer(LA-NSCLC) following radiotherapy(RT). The model,…”
Get full text

Impact of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy (TMT) for muscle-invasive bladder cancer by Ajib, K., Tjong, M., Lunsky, I., Tan, G.H., Nason, G., Erlich, A., Manjula, M., Sridhar, S., Fleshner, N., Zlotta, A., Berlin, A., Chung, P., Kulkarni, G.

Get full text

PT331 - Impact of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy (TMT) for muscle-invasive bladder cancer by Ajib, K., Tjong, M., Lunsky, I., Tan, G.H., Nason, G., Erlich, A., Manjula, M., Sridhar, S., Fleshner, N., Zlotta, A., Berlin, A., Chung, P., Kulkarni, G.

Get full text

Rationale and design of the SafeHeart study: Development and testing of a mHealth tool for the prediction of arrhythmic events and implantable cardioverter-defibrillator therapy by Frodi, Diana M., Kolk, Maarten Z.H., Langford, Joss, Andersen, Tariq O., Knops, Reinoud E., Tan, Hanno L., Svendsen, Jesper H., Tjong, Fleur V.Y., Diederichsen, Soeren Z.

“…Patients with an implantable cardioverter-defibrillator (ICD) are at a high risk of malignant ventricular arrhythmias. The use of remote ICD monitoring,…”
Get full text

Accelerometer-assessed physical behavior and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: A systematic review by Kolk, Maarten Z.H., Frodi, Diana M., Andersen, Tariq O., Langford, Joss, Diederichsen, Soeren Z., Svendsen, Jesper H., Tan, Hanno L., Knops, Reinoud E., Tjong, Fleur V.Y.

“…Current implantable cardioverter-defibrillator (ICD) devices are equipped with a device-embedded accelerometer capable of capturing physical activity (PA). In…”
Get full text

Homolateral Lisfranc Fracture/Dislocation of 1st - 5th Metatarsals in a Collegiate Quarterback: A Case Study by Dayton, Steven R., Krautmann, Kurt M., Boctor, Michael, Tjong, Vehniah K., Kadakia, Anish R.

“…Category: Sports; Midfoot/Forefoot Introduction/Purpose: Lisfranc injuries encompass a spectrum of injuries to the tarsometatarsal (TMT) joint complex from…”
Get full text

Homolateral Lisfranc Dislocation 1-5 in a Collegiate Quarterback: A Case Study by Dayton, Steven R., Krautmann, Kurt M., Boctor, Michael J., Tjong, Vehniah K., Kadakia, Anish R.

“…Background: Lisfranc injuries encompass a spectrum of injuries to the tarsometatarsal (TMT) joint complex from ligamentous sprains to fractures with…”
Get full text

Blood Flow Restriction Therapy Impact on Musculoskeletal Strength and Mass by Dayton, Steven R., Padanilam, Simon J., Sylvester, Tyler C., Boctor, Michael J., Tjong, Vehniah K.

“…Background: Blood flow restriction (BFR) training restricts arterial inflow and venous outflow from the extremity and can produce gains in muscle strength at…”
Get full text

Return to Sport After ACL Reconstruction: Strength and Functionality Testing by Padanilam, Simon J., Dayton, Steven R., Jarema, Ryan, Boctor, Michael J., Tjong, Vehniah K.

“…Background: Functionality testing following anterior cruciate ligament (ACL) reconstruction can benefit clinicians and patients in determining readiness for…”
Get full text